Nuveen LLC Purchases New Holdings in Semler Scientific Inc. $SMLR

Nuveen LLC acquired a new stake in Semler Scientific Inc. (NASDAQ:SMLR - Free Report) in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 27,351 shares of the company's stock, valued at approximately $990,000. Nuveen LLC owned approximately 0.28% of Semler Scientific as of its most recent filing with the SEC.

A number of other large investors also recently added to or reduced their stakes in SMLR. BNP Paribas Financial Markets purchased a new stake in Semler Scientific during the fourth quarter valued at about $30,000. SBI Securities Co. Ltd. lifted its stake in shares of Semler Scientific by 161.3% in the 1st quarter. SBI Securities Co. Ltd. now owns 959 shares of the company's stock valued at $35,000 after acquiring an additional 592 shares during the last quarter. NewEdge Advisors LLC boosted its holdings in Semler Scientific by 318.3% during the 4th quarter. NewEdge Advisors LLC now owns 732 shares of the company's stock valued at $40,000 after acquiring an additional 557 shares during the period. MetLife Investment Management LLC bought a new position in Semler Scientific during the 4th quarter worth approximately $163,000. Finally, Deutsche Bank AG lifted its position in Semler Scientific by 82.0% in the first quarter. Deutsche Bank AG now owns 4,893 shares of the company's stock valued at $177,000 after purchasing an additional 2,204 shares during the last quarter. Hedge funds and other institutional investors own 49.37% of the company's stock.

Semler Scientific Trading Down 3.2%

Shares of NASDAQ SMLR traded down $0.92 during midday trading on Thursday, hitting $28.09. 566,078 shares of the company traded hands, compared to its average volume of 678,255. Semler Scientific Inc. has a 12-month low of $21.77 and a 12-month high of $81.56. The firm has a market cap of $415.87 million, a P/E ratio of 11.56 and a beta of 1.39. The stock has a 50-day moving average price of $36.60 and a 200 day moving average price of $36.87. The company has a debt-to-equity ratio of 0.25, a quick ratio of 0.58 and a current ratio of 0.60.

Semler Scientific (NASDAQ:SMLR - Get Free Report) last posted its quarterly earnings data on Monday, August 4th. The company reported $5.04 earnings per share for the quarter, beating the consensus estimate of ($0.27) by $5.31. Semler Scientific had a return on equity of 43.84% and a net margin of 86.20%.The business had revenue of $8.22 million for the quarter, compared to analysts' expectations of $8.10 million.

Wall Street Analysts Forecast Growth

SMLR has been the topic of several analyst reports. Wall Street Zen downgraded shares of Semler Scientific from a "buy" rating to a "sell" rating in a research note on Thursday, May 22nd. Benchmark initiated coverage on shares of Semler Scientific in a research note on Tuesday, July 8th. They set a "buy" rating and a $101.00 price objective for the company. Maxim Group upgraded Semler Scientific to a "strong-buy" rating and set a $95.00 price target on the stock in a report on Wednesday, July 9th. Finally, Cantor Fitzgerald dropped their price objective on Semler Scientific from $61.00 to $60.00 and set an "overweight" rating for the company in a report on Wednesday, August 6th. One investment analyst has rated the stock with a Strong Buy rating and three have given a Buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Buy" and an average target price of $81.75.

Semler Scientific Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.